Trial Profile
Effect and Safety of Menatetrenone on Treatment of Postmenopausal Osteoporosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Menatetrenone (Primary) ; Alfacalcidol
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Eisai Co Ltd
- 22 Dec 2009 Actual number of patients (240) added as reported by ClinicalTrials.gov.
- 22 Dec 2009 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 01 Jun 2007 Status change from recruiting to completed.